Skip to content
The Kids Research Institute Australia logo
Donate

No results yet

Search

Showing results for "1"

Research

Dendritic cells and multiple sclerosis: Disease, tolerance and therapy

Multiple sclerosis (MS) is a devastating neurological disease that predominantly affects young adults resulting in severe personal and economic impact.

Our research

As WA's first research collaboration dedicated to mental health, we work across The Kids Research Institute Australia and beyond to do the research that the community wants to see happen.

News & Events

Embrace research presented at SMHR conference

Associate Professor Bep Uink and Head of Kulunga Aboriginal Unit Cheryl Bridge watched on by Associate Professor Yael Perry at the SMHR conference.

Research impact

Discover the impact of our achievements in the "real world".

News & Events

Celebrating 35 years of impact at The Kids Research Institute Australia

Coinciding with the Institute’s 35th year of research to improve the health and wellbeing of children and families, the 2025 Impact Report celebrates research which has been translated into policy or practice, and which has led to a paradigm shift in the way we respond to childhood health and wellbeing.

Research

Amped Out: An Energy Drink Study

The Kids Research Institute Australia is conducting a research study to evaluate a 4-month trial ban on the  sale of energy drinks to children in all retail stores in Bridgetown.

Research

The course and prognostic capability of motor difficulties in infants showing early signs of autism

Delays within the motor domain are often overlooked as an early surveillance marker for autism. The present study evaluated motor difficulties and its potential as an early predictive marker for later autism likelihood in a cohort of infants showing early behavioral signs of autism aged 9-14 months. The motor domain was evaluated using the motor subscales of the Mullen Scales of Early Learning at baseline, and at a 6-month follow-up.

Research

A flexible computational pipeline for research analyses of unsolved clinical exome cases

Exome sequencing has enabled molecular diagnoses for rare disease patients but often with initial diagnostic rates of ~25-30%. Here we develop a robust computational pipeline to rank variants for reassessment of unsolved rare disease patients. A comprehensive web-based patient report is generated in which all deleterious variants can be filtered by gene, variant characteristics, OMIM disease and Phenolyzer scores, and all are annotated with an ACMG classification and links to ClinVar.

Research

Effectiveness of a 3 + 0 pneumococcal conjugate vaccine schedule against invasive pneumococcal disease among a birth cohort of 1.4 million children in Australia

Our population-based cohort study demonstrates that >90% coverage in the first year of a universal 3 + 0 PCV program provided high population-level protection

Research

A randomised controlled trial of an iPad-based application to complement early behavioural intervention in Autism Spectrum Disorder

Technology-based interventions may provide a relatively low-cost addition to existing therapist-delivered interventions for children with ASD